Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1083146.RA0IjXLhz8g1i8E1iwX35gMgmVBaGzUuwEdnLsSGN9duM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1083146.RA0IjXLhz8g1i8E1iwX35gMgmVBaGzUuwEdnLsSGN9duM130_assertion type Assertion NP1083146.RA0IjXLhz8g1i8E1iwX35gMgmVBaGzUuwEdnLsSGN9duM130_head.
- NP1083146.RA0IjXLhz8g1i8E1iwX35gMgmVBaGzUuwEdnLsSGN9duM130_assertion description "[In addition, collaborative studies of BMPR2 mutation carriers should enable identification of environmental modifiers, biomarkers for disease development and progression, and surrogate markers for efficacy end points in clinical drug development, thereby providing an invaluable resource for trials of PAH prevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1083146.RA0IjXLhz8g1i8E1iwX35gMgmVBaGzUuwEdnLsSGN9duM130_provenance.
- NP1083146.RA0IjXLhz8g1i8E1iwX35gMgmVBaGzUuwEdnLsSGN9duM130_assertion evidence source_evidence_literature NP1083146.RA0IjXLhz8g1i8E1iwX35gMgmVBaGzUuwEdnLsSGN9duM130_provenance.
- NP1083146.RA0IjXLhz8g1i8E1iwX35gMgmVBaGzUuwEdnLsSGN9duM130_assertion SIO_000772 23733703 NP1083146.RA0IjXLhz8g1i8E1iwX35gMgmVBaGzUuwEdnLsSGN9duM130_provenance.
- NP1083146.RA0IjXLhz8g1i8E1iwX35gMgmVBaGzUuwEdnLsSGN9duM130_assertion wasDerivedFrom befree-2016 NP1083146.RA0IjXLhz8g1i8E1iwX35gMgmVBaGzUuwEdnLsSGN9duM130_provenance.
- NP1083146.RA0IjXLhz8g1i8E1iwX35gMgmVBaGzUuwEdnLsSGN9duM130_assertion wasGeneratedBy ECO_0000203 NP1083146.RA0IjXLhz8g1i8E1iwX35gMgmVBaGzUuwEdnLsSGN9duM130_provenance.